Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823147 · ClinicalTrials.gov registry record · Phase 1
Pain Catastrophizing as a Cause for Systemic Inflammation
A Phase 1 study of Musculoskeletal Pain, sponsored by Beth Darnall, PhD.
- Completed
- Registry status
- Phase 1
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT00823147: Completed Phase 1 study of Musculoskeletal Pain, sponsored by Beth Darnall, PhD.
NCT00823147 is a Phase 1 study of Musculoskeletal Pain that has completed, run by Beth Darnall, PhD. The registered enrollment target is 93 participants, below the 153-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00823147, a Phase 1 study of Musculoskeletal Pain, has completed, sponsored by Beth Darnall, PhD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
Research shows that the immune system is involved in chronic pain. The immune system is involved in the process of inflammation. The investigators are still learning about the factors that cause inflammation, but know it can be measured in the blood. The purpose of this study is to understand how negative thoughts affect the immune system in women with chronic pain. A sub-study asks subjects to store a blood sample for future research by the PI aimed at identifying genetic markers in women with chronic pain.
Conditions Studied
Interventions
- BEHAVIORAL Pain Catastrophizing Induction
Study Locations (1)
Oregon
- Oregon Health and Science Universtiy - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2009-01 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
What the finished NCT00823147 record still lists
NCT00823147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 153-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Musculoskeletal Pain appearing as the primary indexed condition, and to 1 intervention - of which Pain Catastrophizing Induction is the first listed.
NCT00823147 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT00823147 about?
NCT00823147 is a clinical study titled "Pain Catastrophizing as a Cause for Systemic Inflammation". Research shows that the immune system is involved in chronic pain. The immune system is involved in the process of inflammation. The investigators are still learning about the factors that cause inflammation, but know it can be measured in the blood. The purpose of this study is to understand how ne...
What is the current status of trial NCT00823147?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 93 participants. The study started on 2009-01. Estimated completion is 2014-09.
What conditions does trial NCT00823147 study?
This clinical trial studies the following conditions: Musculoskeletal Pain.
What interventions are being tested in trial NCT00823147?
The interventions under investigation include: Pain Catastrophizing Induction (BEHAVIORAL).
Who is sponsoring clinical trial NCT00823147?
This trial is sponsored by Beth Darnall, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00823147 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Musculoskeletal Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00823147's enrollment target sits among peer trials
93 19th of 37 higher than 19 of 37 other Musculoskeletal Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Overlapping Pain Trajectory Study
RECRUITING
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia